ResistanceMap

Data includes aggregated resistance rates for isolates (includes intermediate resistance) from blood and cerebrospinal fluid (i.e., invasive) from inpatients of all ages. Because of differences in scope of collections and testing methods, caution should be exercised in comparing across countries. For more details see methodology.

Country boundaries/designations do not represent CDDEP opinion concerning the legal status of any country, territory, city, or area of its authorities, or concerning the delimitation of its frontiers or boundaries.

Pathogens:

Acinetobacter baumannii

Enterobacter aerogenes/cloacae

Enterococcus faecalis

Enterococcus faecium

Escherichia coli

Klebsiella pneumoniae

Pseudomonas aeruginosa

Salmonella Paratyphi

Salmonella Typhi

Staphylococcus aureus

Streptococcus pneumoniae

Antibiotics

Amikacin

Aminoglycosides

Aminoglycosides (high-level)

Aminopenicillins

Amoxicillin-clavulanate

Ampicillin-sulbactam

Carbapenems

Ceftazidime

Cephalosporins (3rd gen)

Fluoroquinolones

Glycylcyclines

Linezolid

Macrolides

Oxacillin (MRSA)

Penicillins

Piperacillin-tazobactam

Polymyxins

Rifampicin

Vancomycin

Sources

To learn how this data was collected, see our methodology overview.
Boundaries and names shown and the designation used on these maps do not imply the expression of any opinion whatsoever on the part of CDDEP concerning the legal status of any country, territory, city or area of its authorities, or concerning the delimitation of its frontiers or boundaries.

Antibiotics

All Antibiotics

Aminoglycosides

Broad spectrum penicillins

Carbapenems

Cephalosporins

Chloramphenicols

Fluoroquinolones

Glycopeptides

Lipopeptides

Macrolides

Monobactams

Narrow spectrum penicillins

Others

Oxazolidinones

Tetracyclines

Trimethoprim

Sri Lanka

Sources